van der Veen, A.; Minović, I.; van Faassen, M.; Gomes-Neto, A.W.; Berger, S.P.; Bakker, S.J.L.; Kema, I.P.
Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients. J. Clin. Med. 2020, 9, 525.
https://doi.org/10.3390/jcm9020525
AMA Style
van der Veen A, Minović I, van Faassen M, Gomes-Neto AW, Berger SP, Bakker SJL, Kema IP.
Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients. Journal of Clinical Medicine. 2020; 9(2):525.
https://doi.org/10.3390/jcm9020525
Chicago/Turabian Style
van der Veen, Anna, Isidor Minović, Martijn van Faassen, Antόnio W. Gomes-Neto, Stefan P. Berger, Stephan J. L. Bakker, and Ido P. Kema.
2020. "Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients" Journal of Clinical Medicine 9, no. 2: 525.
https://doi.org/10.3390/jcm9020525
APA Style
van der Veen, A., Minović, I., van Faassen, M., Gomes-Neto, A. W., Berger, S. P., Bakker, S. J. L., & Kema, I. P.
(2020). Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients. Journal of Clinical Medicine, 9(2), 525.
https://doi.org/10.3390/jcm9020525